426 related articles for article (PubMed ID: 19065671)
21. The cAMP-activated GTP exchange factor, Epac1 upregulates plasma membrane and nuclear Akt kinase activities in 8-CPT-2-O-Me-cAMP-stimulated macrophages: Gene silencing of the cAMP-activated GTP exchange Epac1 prevents 8-CPT-2-O-Me-cAMP activation of Akt activity in macrophages.
Misra UK; Kaczowka S; Pizzo SV
Cell Signal; 2008 Aug; 20(8):1459-70. PubMed ID: 18495429
[TBL] [Abstract][Full Text] [Related]
22. Protein kinase A-dependent pSer(675) -β-catenin, a novel signaling defect in a mouse model of congenital hepatic fibrosis.
Spirli C; Locatelli L; Morell CM; Fiorotto R; Morton SD; Cadamuro M; Fabris L; Strazzabosco M
Hepatology; 2013 Nov; 58(5):1713-23. PubMed ID: 23744610
[TBL] [Abstract][Full Text] [Related]
23. Combination of a Histone Deacetylase 6 Inhibitor and a Somatostatin Receptor Agonist Synergistically Reduces Hepatorenal Cystogenesis in an Animal Model of Polycystic Liver Disease.
Lorenzo Pisarello M; Masyuk TV; Gradilone SA; Masyuk AI; Ding JF; Lee PY; LaRusso NF
Am J Pathol; 2018 Apr; 188(4):981-994. PubMed ID: 29366679
[TBL] [Abstract][Full Text] [Related]
24. Telmisartan ameliorates fibrocystic liver disease in an orthologous rat model of human autosomal recessive polycystic kidney disease.
Yoshihara D; Kugita M; Sasaki M; Horie S; Nakanishi K; Abe T; Aukema HM; Yamaguchi T; Nagao S
PLoS One; 2013; 8(12):e81480. PubMed ID: 24324698
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA15a modulates expression of the cell-cycle regulator Cdc25A and affects hepatic cystogenesis in a rat model of polycystic kidney disease.
Lee SO; Masyuk T; Splinter P; Banales JM; Masyuk A; Stroope A; Larusso N
J Clin Invest; 2008 Nov; 118(11):3714-24. PubMed ID: 18949056
[TBL] [Abstract][Full Text] [Related]
26. Epac activation converts cAMP from a proliferative into a differentiation signal in PC12 cells.
Kiermayer S; Biondi RM; Imig J; Plotz G; Haupenthal J; Zeuzem S; Piiper A
Mol Biol Cell; 2005 Dec; 16(12):5639-48. PubMed ID: 16207818
[TBL] [Abstract][Full Text] [Related]
27. Regulation of sodium-proton exchanger isoform 3 (NHE3) by PKA and exchange protein directly activated by cAMP (EPAC).
Honegger KJ; Capuano P; Winter C; Bacic D; Stange G; Wagner CA; Biber J; Murer H; Hernando N
Proc Natl Acad Sci U S A; 2006 Jan; 103(3):803-8. PubMed ID: 16407144
[TBL] [Abstract][Full Text] [Related]
28. Histamine stimulates the proliferation of small and large cholangiocytes by activation of both IP3/Ca2+ and cAMP-dependent signaling mechanisms.
Francis HL; Demorrow S; Franchitto A; Venter JK; Mancinelli RA; White MA; Meng F; Ueno Y; Carpino G; Renzi A; Baker KK; Shine HE; Francis TC; Gaudio E; Alpini GD; Onori P
Lab Invest; 2012 Feb; 92(2):282-94. PubMed ID: 22064319
[TBL] [Abstract][Full Text] [Related]
29. PKA and Epac cooperate to augment bradykinin-induced interleukin-8 release from human airway smooth muscle cells.
Roscioni SS; Kistemaker LE; Menzen MH; Elzinga CR; Gosens R; Halayko AJ; Meurs H; Schmidt M
Respir Res; 2009 Sep; 10(1):88. PubMed ID: 19788733
[TBL] [Abstract][Full Text] [Related]
30. Prostaglandin E2 inhibits specific lung fibroblast functions via selective actions of PKA and Epac-1.
Huang SK; Wettlaufer SH; Chung J; Peters-Golden M
Am J Respir Cell Mol Biol; 2008 Oct; 39(4):482-9. PubMed ID: 18421013
[TBL] [Abstract][Full Text] [Related]
31. Exchange proteins directly activated by cAMP induce the proliferation of rat anterior pituitary GH3 cells via the activation of extracellular signal-regulated kinase.
Sun W; Jiao W; Huang Y; Li R; Zhang Z; Wang J; Lei T
Biochem Biophys Res Commun; 2017 Apr; 485(2):355-359. PubMed ID: 28216156
[TBL] [Abstract][Full Text] [Related]
32. The cyclic AMP-Epac1-Rap1 pathway is dissociated from regulation of effector functions in monocytes but acquires immunoregulatory function in mature macrophages.
Bryn T; Mahic M; Enserink JM; Schwede F; Aandahl EM; Taskén K
J Immunol; 2006 Jun; 176(12):7361-70. PubMed ID: 16751380
[TBL] [Abstract][Full Text] [Related]
33. Pasireotide is more effective than octreotide in reducing hepatorenal cystogenesis in rodents with polycystic kidney and liver diseases.
Masyuk TV; Radtke BN; Stroope AJ; Banales JM; Gradilone SA; Huang B; Masyuk AI; Hogan MC; Torres VE; Larusso NF
Hepatology; 2013 Jul; 58(1):409-21. PubMed ID: 23172758
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of metalloprotease hyperactivity in cystic cholangiocytes halts the development of polycystic liver diseases.
Urribarri AD; Munoz-Garrido P; Perugorria MJ; Erice O; Merino-Azpitarte M; Arbelaiz A; Lozano E; Hijona E; Jiménez-Agüero R; Fernandez-Barrena MG; Jimeno JP; Marzioni M; Marin JJ; Masyuk TV; LaRusso NF; Prieto J; Bujanda L; Banales JM
Gut; 2014 Oct; 63(10):1658-67. PubMed ID: 24436140
[TBL] [Abstract][Full Text] [Related]
35. Cyclic AMP/PKA-dependent paradoxical activation of Raf/MEK/ERK signaling in polycystin-2 defective mice treated with sorafenib.
Spirli C; Morell CM; Locatelli L; Okolicsanyi S; Ferrero C; Kim AK; Fabris L; Fiorotto R; Strazzabosco M
Hepatology; 2012 Dec; 56(6):2363-74. PubMed ID: 22653837
[TBL] [Abstract][Full Text] [Related]
36. Defects in cholangiocyte fibrocystin expression and ciliary structure in the PCK rat.
Masyuk TV; Huang BQ; Ward CJ; Masyuk AI; Yuan D; Splinter PL; Punyashthiti R; Ritman EL; Torres VE; Harris PC; LaRusso NF
Gastroenterology; 2003 Nov; 125(5):1303-10. PubMed ID: 14598246
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of Cdc25A suppresses hepato-renal cystogenesis in rodent models of polycystic kidney and liver disease.
Masyuk TV; Radtke BN; Stroope AJ; Banales JM; Masyuk AI; Gradilone SA; Gajdos GB; Chandok N; Bakeberg JL; Ward CJ; Ritman EL; Kiyokawa H; LaRusso NF
Gastroenterology; 2012 Mar; 142(3):622-633.e4. PubMed ID: 22155366
[TBL] [Abstract][Full Text] [Related]
38. Adenylyl cyclase 5 links changes in calcium homeostasis to cAMP-dependent cyst growth in polycystic liver disease.
Spirli C; Mariotti V; Villani A; Fabris L; Fiorotto R; Strazzabosco M
J Hepatol; 2017 Mar; 66(3):571-580. PubMed ID: 27826057
[TBL] [Abstract][Full Text] [Related]
39. Rac GTPase is a hub for protein kinase A and Epac signaling in endothelial barrier protection by cAMP.
Birukova AA; Burdette D; Moldobaeva N; Xing J; Fu P; Birukov KG
Microvasc Res; 2010 Mar; 79(2):128-38. PubMed ID: 19962392
[TBL] [Abstract][Full Text] [Related]
40. Activation of PKA and Epac proteins by cyclic AMP depletes intracellular calcium stores and reduces calcium availability for vasoconstriction.
Cuíñas A; García-Morales V; Viña D; Gil-Longo J; Campos-Toimil M
Life Sci; 2016 Jun; 155():102-9. PubMed ID: 27142830
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
